Laurel Copeland to Analgesics, Opioid
This is a "connection" page, showing publications Laurel Copeland has written about Analgesics, Opioid.
Connection Strength
1.169
-
Salas J, Miller MB, Scherrer JF, Moore R, McCrae CS, Sullivan MD, Bucholz KK, Copeland LA, Ahmedani BK, Schneider FD, Lustman PJ. The association of opioid use duration and new depression episode among patients with and without insomnia. J Opioid Manag. 2020 Sep/Oct 2020; 16(5):317-328.
Score: 0.122
-
Owen-Smith A, Stewart C, Sesay MM, Strasser SM, Yarborough BJ, Ahmedani B, Miller-Matero LR, Waring SC, Haller IV, Waitzfelder BE, Sterling SA, Campbell CI, Hechter RC, Zeber JE, Copeland LA, Scherrer JF, Rossom R, Simon G. Chronic pain diagnoses and opioid dispensings among insured individuals with serious mental illness. BMC Psychiatry. 2020 01 31; 20(1):40.
Score: 0.117
-
Dasinger EA, Graham LA, Wahl TS, Richman JS, Baker SJ, Hawn MT, Hernandez-Boussard T, Rosen AK, Mull HJ, Copeland LA, Whittle JC, Burns EA, Morris MS. Preoperative opioid use and postoperative pain associated with surgical readmissions. Am J Surg. 2019 11; 218(5):828-835.
Score: 0.110
-
Shafi S, Collinsworth AW, Copeland LA, Ogola GO, Qiu T, Kouznetsova M, Liao IC, Mears N, Pham AT, Wan GJ, Masica AL. Association of Opioid-Related Adverse Drug Events With Clinical and Cost Outcomes Among Surgical Patients in a Large Integrated Health Care Delivery System. JAMA Surg. 2018 08 01; 153(8):757-763.
Score: 0.106
-
Scherrer JF, Salas J, Sullivan MD, Ahmedani BK, Copeland LA, Bucholz KK, Burroughs T, Schneider FD, Lustman PJ. Impact of adherence to antidepressants on long-term prescription opioid use cessation. Br J Psychiatry. 2018 02; 212(2):103-111.
Score: 0.102
-
Salas J, Scherrer JF, Ahmedani BK, Copeland LA, Bucholz KK, Sullivan MD, Burroughs T, Schneider FD, Lustman PJ. Gender and the Association between Long-Term Prescription Opioid Use and New-Onset Depression. J Pain. 2018 01; 19(1):88-98.
Score: 0.100
-
Salas J, Scherrer JF, Schneider FD, Sullivan MD, Bucholz KK, Burroughs T, Copeland LA, Ahmedani BK, Lustman PJ. New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation. Pain. 2017 02; 158(2):306-312.
Score: 0.095
-
Scherrer JF, Salas J, Sullivan MD, Schneider FD, Bucholz KK, Burroughs T, Copeland L, Ahmedani B, Lustman PJ. The influence of prescription opioid use duration and dose on development of treatment resistant depression. Prev Med. 2016 10; 91:110-116.
Score: 0.092
-
Scherrer JF, Salas J, Copeland LA, Stock EM, Schneider FD, Sullivan M, Bucholz KK, Burroughs T, Lustman PJ. Response to Ruan et?al. Letter to the Editor: Increased Risk of Depression Recurrence After Initiation of Prescription Opioids in?Noncancer Pain Patients. J Pain. 2016 08; 17(8):946-7.
Score: 0.092
-
Scherrer JF, Salas J, Copeland LA, Stock EM, Schneider FD, Sullivan M, Bucholz KK, Burroughs T, Lustman PJ. Increased Risk of Depression Recurrence After Initiation of Prescription Opioids in Noncancer Pain Patients. J Pain. 2016 Apr; 17(4):473-82.
Score: 0.089
-
Scherrer JF, Salas J, Copeland LA, Stock EM, Ahmedani BK, Sullivan MD, Burroughs T, Schneider FD, Bucholz KK, Lustman PJ. Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations. Ann Fam Med. 2016 Jan-Feb; 14(1):54-62.
Score: 0.089
-
Scherrer JF, Salas J, Grucza R, Sullivan MD, Lustman PJ, Copeland LA, Ballantyne JC. Depression and Buprenorphine Treatment in Patients with Non-cancer Pain and Prescription Opioid Dependence without Comorbid Substance Use Disorders. J Affect Disord. 2021 01 01; 278:563-569.
Score: 0.031
-
Scherrer JF, Salas J, Bucholz KK, Schneider FD, Burroughs T, Copeland LA, Sullivan MD, Lustman PJ. New depression diagnosis following prescription of codeine, hydrocodone or oxycodone. Pharmacoepidemiol Drug Saf. 2016 05; 25(5):560-8.
Score: 0.022